![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR
Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Italy (S.C., E.M., R.D.P.); IRCCS Centro Neurolesi "Bonino-Pulejo," Messina, Italy (S.C., E.M., R.D.P.); Department of Experimental Pharmacology, University of Naples "Federico II", Naples, Italy (E.E.); Department of Pharmacological and Physiological Science, St. Louis University School of Medicine, St. Louis, Missouri (H.M., G.M.M., D.S.); Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, St. Louis University School of Medicine, St. Louis, Missouri (G.M.M., D.S.)
Received for publication
May 19, 2006
Accepted
June 29, 2006.
 |
Abstract |
|---|
 Top Abstract Materials and MethodsResultsDiscussionReferences |
|---|
). The cause of the systemic vasodilation associated with shock, in particular, is still unclear, although overproduction of the potent vasodilator nitric oxide (NO) from the inducible form of nitric-oxide synthase (iNOS) has been implicated (Nathan, 1992; Thiemermann, 1994; Rixen et al., 1997). Even so, results from iNOS knockout mice have been controversial, with some studies reporting reduced endotoxin-related hypotension and others indicating no effects or even detrimental outcomes (Nicholson et al., 1999). Furthermore, the extensive evaluation of selective inhibitors for iNOS, such as aminoguanidine and N-iminoethyl-L-lysine in models of shock, have likewise been disappointing and controversial (Thiemermann et al., 1995; Parratt, 1997).
In septic shock, inhibition of the activity of the constitutive endothelial cell isoform of nitric-oxide synthase (eNOS) precedes the induction of iNOS (Lu et al., 1996). Moreover, down-regulation of eNOS occurs at time points similar to those where iNOS induction is seen. Collectively, these results indicate that the beneficial effects of NO from eNOS are probably lost in septic shock associated with Gram-negative endotoxemia. In this context, nitric oxide from eNOS plays an important homoeostatic role in maintaining appropriate blood flow to vital organs, such as the kidney, liver, and lungs and exhibits cytoprotective effects, in part, by preventing platelet/neutrophil adhesion to the blood vessel wall (Forstermann et al., 1998). Therefore, it is conceivable that a critical residual fraction of NO derived from iNOS is required for vital organ perfusion and blood vessel potency. Thus, its inhibition will be overall detrimental. This may explain, at least in part, the controversial reports on iNOS inhibitors. We reasoned that blocking peroxynitrite, a powerful and potent proapoptotic and proinflammatory mediator (Salvemini et al., 1998a), would yield better outcomes. This hypothesis stems from the fact that removal or antagonism of ONOO- in endotoxic shock will not deplete homeostatic levels of NO produced from iNOS but rather only attenuate the harmful effects of NO overproduced from iNOS (which are mediated by ONOO-). Peroxynitrite (the byproduct of the reaction between NO and 
) has been increasingly implicated in the pathogenesis of endotoxin-induced hemodynamic instability and organ dysfunction (Beckman et al., 1990; Beckman, 1996; Zingarelli et al., 1998).
Peroxynitrite is known to undergo acid-catalyzed decomposition by two distinct pathways (Salvemini et al., 1998b; Groves, 1999). Isomerization to nitrate is the major decay route, but a significant portion of the decomposition produces a species with reactivity related to that of a hydroxyl radical (Crow et al., 1994). Certain water-soluble iron (III) porphyrins are highly active ONOO- decomposition catalysts, and they function by catalyzing the isomerization of ONOO- almost exclusively to nitrate (Stern et al., 1996). Catalysis is proposed to proceed via an oxo-Fe(IV) intermediate generated from the metal-promoted cleavage of the O-O bond. Subsequent recombination with NO2 regenerates the Fe(III) state and produces nitrate. These catalysts thus dramatically increase the rate of ONOO- isomerization, preempting the formation of oxidizing radical species and generating the harmless nitrate anion. This mode of catalysis manifests itself by dramatic shifts in the resulting nitrite-to-nitrate ratio when compared with the proton-catalyzed decomposition (Stern et al., 1996; Salvemini et al., 1998b; Shimanovich et al., 2001).
In the present study, we have examined the role of ONOO- by using the peroxynitrite decomposition catalysts 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron III chloride (FeTTPs). This compound is a water-soluble Fe (III) porphyrin complex that catalyzes rapid isomerization of ONOO- to nitrate (
) under physiologically relevant conditions (pH 7.4, 37°C) (Jensen and Riley 2002). The cytoprotective actions of FeTPPs have been characterized (Stern et al., 1996; Misko et al., 1998). In addition to peroxynitrite-decomposing effect, FeTPPs demonstrates minimal superoxide dismutase activity and does not complex with NO (Lee et al., 1998; Misko et al., 1998; Imam et al., 2000). In fact, the peroxynitrite-decomposing effect increases considerably if superoxide and peroxynitrite are present in the same milieu as a result of the formation of catalytic cycle (Lee et al., 1998). As shown in previous studies, FeTTPs and other derivatives of similar (e.g., FeTMPS) and different (e.g., F15) chemical class exert potent anti-inflammatory properties across several disease states (Salvemini et al., 1998b; Cuzzocrea et al., 2000; Obrosova et al., 2005). The results of our studies indicate that the function of eNOS was compromised during endotoxic shock and that, although iNOS inhibitors attenuated arterial hypotension, they had no effect on overall survival. In contrast, FeTPPs prevented hypotension, improved mortality, preserved multiple organ function, and mitigated endothelial cell dysfunction. These results strongly suggest that use of iNOS inhibitors has little benefit early after endotoxemia where eNOS is compromised and that alternative strategies, such as removal of peroxynitrite, may yield better outcomes overall.
|
Materials and Methods |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Drug Administration. LPS (serotype 0111:B4) was purchased from Sigma (St. Louis, MO). Lipopolysaccharides contain endotoxin levels of not less than 500,000 EU (endotoxin units)/mg unless otherwise noted. One nanogram of endotoxin is equivalent to 5 (Limulus lysate assay) and 10 EU (chromogenic assay). LPS (4 mg/kg) was administered by bolus intravenous (i.v.) injection in a volume of 0.3 ml as a slow injection over 15 min. All animals then received a continuous infusion of saline (4 mg/kg/h i.v.). A further group of animals received 30 min before the administration of endotoxin an infusion of either a low dose (3 mg/kg/h) or a high dose (10 mg/kg/h) of the selective iNOS inhibitor N-(3-(aminomethyl)benzyl)acetamidine (1400W, in 4 ml/kg/h saline). Infusion of 1400W was preceded by bolus injections of 3 or 10 mg/kg i.v. In other experimental groups, the animals received FeTPPs (10-100 mg/kg i.v.) 1 h prior to LPS. Surviving animals were sacrificed at 9 h after the administration of LPS or saline as dictated by the animal experimental protocol. Ten rats per group were used.
Quantization of Organ Function and Injury. Six hours after LPS or saline injection, blood samples were collected from all animals (n = 10 for each group). The blood sample was centrifuged (1610g for 3 min at room temperature) to separate plasma. All plasma samples were analyzed within 24 h by a veterinary clinical laboratory using standard laboratory techniques. The following marker enzymes were measured in the plasma as biochemical indicators of organ injury/dysfunction of the kidneys, pancreas, and liver. 1) Renal dysfunction was determined and assessed by measuring the increases in plasma levels of creatinine (an indicator of reduced glomerular filtration rate). 2) Pancreatic injury was inferred from increases in serum levels of lipase and amylase, and 3) liver injury was assessed by measuring the rise in plasma levels of bilirubin, alkaline phosphatase, aspartate aminotransferase (AST, a nonspecific marker for hepatic injury), and alanine aminotransferase (ALT, a specific marker for hepatic parenchymal injury).
Light Microscopy. Standardized liver biopsies were taken at the end of experiments, fixed for 1 week in buffered formaldehyde solution (10% in phosphate-buffered saline) at room temperature, dehydrated by graded ethanol, and embedded in Paraplast (Sherwood Medical, Mahwah, NJ). Sections (thickness 7 µm) were deparaffinized with xylene, stained with hematoxylin and eosin, and studied using light microscopy (Dialux 22 Leitz).
Immunohistochemical Localization of Nitrotyrosine. Tyrosine nitration, an index of the nitration of proteins by peroxynitrite and/or oxygen-derived free radicals, was determined by immunohistochemistry as described previously (Misko et al., 1993). At 6 h after LPS or saline injection, the relevant organs were fixed in 10% buffered formaldehyde, and 8-µm sections were prepared from paraffin-embedded tissues. After deparaffinization, endogenous peroxidase was quenched with 0.3% H2O2 in 60% methanol for 30 min, after which sections were permeabilized with 0.1% Triton X-100 in phosphate-buffered saline for 20 min. Nonspecific adsorption was minimized by incubating the section in 2% normal goat serum in phosphate-buffered saline for 20 min. Endogenous biotin or avidin binding sites were blocked by sequential incubation for 15 min with avidin and biotin. The sections were then incubated overnight with 1:1000 dilution of primary antinitrotyrosine antibody or with control solutions. Controls included buffer alone or nonspecific purified rabbit IgG. Specific labeling was detected with a biotin-conjugated goat anti-rabbit IgG and avidin-biotin peroxidase complex. To confirm that the immunoreactions for the nitrotyrosine were specific, some sections were also incubated with the primary antibody (antinitrotyrosine) in the presence of excess nitrotyrosine (10 mM) to verify the binding specificity.
Isolated Tissue Experiments. Four aortic rings were prepared from each of 10 rats. In brief, thoracic aortas were removed from male Sprague-Dawley rats and treated with LPS (4 mg/kg i.v.), LPS plus FeTPPs (100 mg/kg i.v.), or an equal volume of saline. Thoracic aortas were removed at 2 h post-treatment, and connective tissue was carefully trimmed to avoid damage to the endothelium. Rings were cut into 3 mm lengths and placed into a 10-ml tissue bath. In some experiments, the endothelium was removed by gentle rubbing of the ring preparation. Successful removal of the endothelium was confirmed by the lack of a relaxation response to acetylcholine (10-6 M). Aortic rings were maintained at 37°C in Krebs' bicarbonate buffer, pH 7.4, bubbled with 5% CO2/95% O2. Rings were preloaded with 1 g of tension and equilibrated for 30 min with two to three buffer changes. After stabilization of the baseline, the rings were contracted with phenylephrine. Doses of phenylephrine that produced 90 to 100% contraction were chosen for subsequent experiments. NO-mediated relaxation of the precontracted endothelium-intact rings was produced by cumulative increases in the concentration of exogenously added acetylcholine. Endothelium-independent relaxation was evoked by administration of the NO donor, sodium nitroprusside, using endothelium-denuded rings. Isometric tension was recorded, and relaxation was determined as the percentage of maximal tone developed to phenylephrine.
Nitrite/Nitrate Assay. NO reacts with oxygen to yield nitrate and nitrite. Therefore, we measured these breakdown products of NO by means of the fluorometric assay for the measurement of nitrite as described in detail by Misko et al. (1993). Plasma samples were first passed through an Ultra-MC filter (10,000 molecular weight cut-off; Millipore, Bedford, MA). Nitrate in plasma aliquots (5 µl) was converted to nitrite by the addition of nitrate reductase (14 
) and the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH, 1 nmol) with incubation for 10 min at room temperature. The reaction was terminated by dilution with water and the addition of the diaminonapthalene reagent (Misko, 1993). Nitrite concentrations in these samples were determined fluorimetrically (excitation at 365 nm and emission at 450 nm) with sodium nitrite used as a standard. All determinations were performed in duplicate, and results were expressed as plasma NOx levels (in micromolars). Plasma NOx were measured up to 6 h post-LPS.
Materials. The composition of the Krebs' buffer was as follows: 119 mM NaCl, 2.5 mM KCl, 1.3 mM MgSO4, 2.5 mM CaCl2, 1.0 mM NaH2PO4, 26.2 mM NaHCO3, and 10 mM HEPES, pH 7.4. FeTPPs was obtained from Calbiochem (Inalco, Milan, Italy). LPS, phenylephrine, acetylcholine, sodium nitroprusside, and aminoguanidine were all obtained from Sigma. 1400W was purchased from Alexis Biochemicals (San Diego, CA).
|
|
|
Results |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Effect of the Peroxynitrite Decomposition Catalyst FeTPPs on Shock and Survival
Baseline levels of mean arterial blood pressure in all groups of animals ranged from 125 ± 3 to 130 ± 5 mm Hg and were not significantly different between groups (Fig. 2). In saline control rats (no endotoxin), administration of FeTPPs, at the highest dose tested (30 mg/kg i.v.), had no effect on mean arterial blood pressure (data not shown). In endotoxemic rats, there was a time dependent fall in mean arterial pressure which uniformly resulted in death at approximately 7 h (Fig. 3). However, administration of FeTPPs 1 h prior to endotoxemia dose dependently inhibited (10-100 mg/kg; Fig. 3) arterial hypotension. Furthermore, at doses of 10 and 30 mg/kg, FeTPPs also significantly prevented mortality up to the 9 h time point (Fig. 3).
|
|
Pancreatic Injury. No significant alterations in plasma levels of lipase and amylase were observed in saline-infused animals (Fig. 3, B and C). In contrast, at 6 h post-LPS injection, significant increases in plasma levels of lipase and amylase were observed (Fig. 3, B and C) and this event was blocked by FeTPPs (100 mg/kg) (Fig. 3, B and C).
Liver Injury. No significant elevations in the plasma levels of ALT, AST, bilirubin, and alkaline phosphatase were noted in saline control rats (Fig. 4). In contrast, at 6 h post-LPS injection, significant elevations in plasma levels of ALT, AST, bilirubin, and alkaline phosphatase, compatible with the development of hepatocellular injury and cholestasis, were observed (Fig. 4). Treatment with 100 mg/kg FeTPPs abolished the liver dysfunction caused by LPS (Fig. 4).
|
|
In conjunction with these findings and at the same time points, the livers of E. coli endotoxin-challenged rats showed substantial histological alterations consistent with LPS-induced organ injury (Fig. 6, A and A1) compared with organs obtained from saline-infused rats (Fig. 6C). Most notably, hepatic damage was characterized by focal damage of the hepatic parenchyma (Fig. 6A1) along with infiltration of inflammatory cells (Fig. 6A, see arrow). These LPS-induced histopathological changes were attenuated in the organs of rats treated with FeTPPs (100 mg/kg; Fig. 6B).
Aortic Contractility and Endothelial Function. In separate experiments, rats were treated with LPS (4 mg/kg) or saline and sacrificed 2 h later with their aortas isolated and placed in organ baths as described previously. Phenylephrine (Phe, 10-9-10-4 M) caused a dose-dependent contraction of saline control tissues with an EC50 of 1.9 x 10-8 M (Fig. 7). The dose-response curve to phenylephrine in tissues taken from endotoxemic LPS-treated rats showed a significant shift to the right, indicative of an inhibition of contractile activity. The EC50 for phenylephrine was thus 1.1 x 10-6 M (Fig. 7).
|
|
|
Discussion |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
) and in animal models (Macarthur et al., 1999, 2000). The mechanisms implicated in LPS-mediated impairment of endothelium-dependent vasodilation include inhibition of eNOS enzymatic activity and/or down-regulation of eNOS expression (Lu et al., 1996). Alterations in eNOS have thus been found at both early and late time points after cellular exposure to endotoxin. For instance, in cultured endothelial cells, LPS and various cytokines decrease agonist-mediated NO release within 30 min (Graier et al., 1994). These same cytokines, including tumor necrosis factor-
, have been shown to attenuate eNOS expression by reductions in eNOS mRNA stability at the later time points (Yoshizumi et al., 1993). Thus, by the time iNOS is up-regulated, there is a well established corresponding down-regulation in eNOS expression (Yoshizumi et al., 1993).
The findings reported here show that inhibition of iNOS in this model of endotoxic shock elicits short-term hemodynamic stabilization without meaningfully improving survival rate. We believe that such lack of effect is due to the dependence, especially in the later stages of shock, on iNOS as the prime source of NO. Our results in the isolated aortic ring tissue experiments support this contention, as they clearly show a significant loss in eNOS activity (as assessed by monitoring the responses to acetylcholine, an endothelium-dependent vasodilator) at a time point where iNOS was already induced (e.g., 2 h post-LPS). It is also clear from our experiments that responses to the endothelium-independent vasodilator sodium nitroprusside were not affected, thereby indicating that the function of soluble guanylate cyclase in smooth muscle cells was preserved. In the present study, we did not determine whether loss of endothelium-dependent vasorelaxation (and thus NO release) was due to inhibitory effects on eNOS activity or down-regulation of the expression. The former possibility is more plausible because down-regulation of eNOS mRNA and protein levels by LPS/cytokines require at least three or more pathways (Yoshizumi et al., 1993). Other reports have also alluded to this concept of dependence on iNOS as the prime source of homeostatic NO during circulatory shock, especially in critical organs such as the lung. Thus, inhibition of iNOS worsened rather than improved acute respiratory distress syndrome in animal models (Cobb et al., 1999). Likewise, endotoxin down-regulates eNOS in renal arteries, leading to impaired endothelium-dependent vasodilation (Lu et al., 1996), and in rodent models of shock, resulting in NO derived from iNOS becoming the major source of this vasodilator (Lu et al., 1996). Finally, septic shock studies involving iNOS knockout mice have demonstrated that such animals have a much greater mortality rate than their wild-type counterparts, again underscoring the importance of iNOS in septic shock (Cobb et al., 1999).
|
). In contrast, better outcomes have been more consistently observed following inhibition of peroxynitrite formation. Szabò et al. (1995) demonstrated that ONOO- is formed in the earliest stage of endotoxemia (when eNOS-derived NO combines with superoxide). This early formation is associated with important deleterious effects of peroxynitrite on vascular contractile and endothelial dysfunction (Zingarelli et al., 1997). The beneficial effect of FeTTPs observed in the present study may be partially dependent on the inhibition of early ONOO- production. 1400W will not block early formation of ONOO-.
These findings suggest that ONOO- is responsible, at least in part, for the development of endotoxin-induced hypotension, endothelial injury, multiple organ dysfunction, and subsequent death. In support of these results, recent data demonstrate that ONOO- is capable of mimicking many of the cardiovascular alterations associated with shock (endothelial dysfunction, vascular hyporeactivity, myocardial impairment, and cellular energetic failure) (O'Connor et al., 1997). Moreover, recently it has been demonstrated that FP15, another ONOO- decomposition catalyst, also exerts vascular protective and anti-inflammatory effects in many models (Obrosova et al., 2005). Furthermore, ONOO- has been implicated in tissue damage, including the intestinal damage that accompanies endotoxic shock (Salvemini et al., 1999) and has been detected in humans with sepsis (Fukuyama et al., 1997). Peroxynitrite can also cause DNA single-strand damage triggering poly(ADP-ribose) polymerase (PARP) activation, ultimately leading to cell death (Szabo et al., 1997). The involvement of PARP in the pathophysiology of endotoxin shock and the utility of PARP inhibitors in this context has been described previously (Wray et al., 1998).
Therefore, we contend that development of therapeutic strategies for the treatment of Gram-negative septic shock that distinguish between the overtly harmful effects of NO overproduction from the beneficial effects of residual homeostatic NO availability is likely to be more promising than approaches that fail to acknowledge these separate NO-mediated actions. Strategies aimed at directly removing ONOO- or inhibiting signaling events engaged by ONOO- (i.e., activation of PARP) may yield a better overall outcome (Fig. 9).
|
Acknowledgements |
|---|
|
Footnotes |
|---|
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
ABBREVIATIONS: NO, nitric oxide; FeTTPs, 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron III chloride; LPS, lipopolysaccharide; iNOS, inducible nitric-oxide synthase; ONOO-, peroxynitrite; MAP, mean arterial pressure; NOx, nitrite/nitrate; eNOS, endothelial nitric-oxide synthase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; NADPH, nicotinamide adenine dinucleotide phosphate; 1400W, N-(3-(aminomethyl)benzyl)acetamidine; PARP, poly(ADP-ribose) polymerase; i.v., intravenous.
Address correspondence to: Dr. Daniela Salvemini, Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, St. Louis University Hospital, 3635 Vista Avenue, St. Louis, MO 63110-0250. E-mail: salvemd{at}slu.edu
|
References |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Beckman JS, Beckman TW, Chen J, Marshall PA, and Freman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624.
Beckman JS (1996) Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9: 836-844.[CrossRef][Medline]
Bhagat K, Collier J, and Vallance P (1996) Local venous responses to endotoxin in humans. Circulation 94: 490-497.
Cobb JP, Hotchkiss RS, Swanson PE, Chang K, Qiu Y, Laubach VE, Karl IE, and Buchman TG (1999) Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. Surgery 126: 438-442.[Medline]
Crow JP, Spruell C, Chen J, Gunn C, Ischiropoulos H, Tsai M, Smith CD, Radi R, Koppenol WH, and Beckman JS (1994) On the pH-dependent yield of hydroxyl radical products from peroxynitrite. Free Radic Biol Med 16: 331-338.[CrossRef][Medline]
Cuzzocrea S, Misko TP, Costantino G, Mazzon E, Micali A, Caputi AP, Macarthur H, and Salvemini D (2000) Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J 14: 1061-1072.
Forstermann U, Boissel JP, and Kleinert H (1998) Expressional control of the `constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 12: 773-790.
Fukuyama N, Takebayashi Y, Hida M, Ishida H, Ichimori K, and Nakazawa H (1997) Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock. Free Radic Biol Med 22: 771-774.[CrossRef][Medline]
Graier WF, Myers PR, Rubin LJ, Adams HR, and Parker JL (1994) Escherichia coli endotoxin inhibits agonist-mediated cytosolic Ca2+ mobilization and nitric oxide biosynthesis in cultured endothelial cells. Circ Res 75: 659-668.
Groves JT (1999) Peroxynitrite: reactive, invasive and enigmatic. Curr Opin Chem Biol 3: 226-235.[CrossRef][Medline]
Imam SZ, Islam F, Itzhak Y, Slikker W Jr, and Ali SF (2000) Prevention of dopaminergic neurotoxicity by targeting nitric oxide and peroxynitrite: implications for the prevention of methamphetamine-induced neurotoxic damage. Ann NY Acad Sci 914: 157-171.[Medline]
Jensen M and Riley D (2002) Peroxynitrite decomposition activity of iron porphyrin complexes. Inorg Chem 41: 4788-4797.[CrossRef][Medline]
Kubes P (1993) Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol 264: G143-G149.[Medline]
Lee J, Hunt J, and Groves JT (1998) Mechanisms of iron porphyrin reactions with peroxynitrite. Am J Chem Soc 120: 7493-7501.[CrossRef]
Lu JL, Schmiege LM 3rd, Kuo L, and Liao JC (1996) Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. Biochem Biophys Res Commun 225: 1-5.[CrossRef][Medline]
Macarthur H, Salvemini D, and Westfall TC (1999) Peroxynitrite is involved in the development of hyporeactivity to norepinephrine in endotoxemia. FASEB J 13: A757.
Macarthur H, Westfall TC, Riley DP, Misko TP, and Salvemini D (2000) Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci USA 97: 9753-9758.
Misko TP, Schilling RJ, Salvemini DS, Moore WM, and Currie MG (1993) A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 214: 11-16.[CrossRef][Medline]
Misko TP, Highkin MK, Veenhuizen AW, Manning PT, Stern MK, Currie MG, and Salvemini D (1998) Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J Biol Chem 273: 15646-15653.
Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064.[Abstract]
Nicholson SC, Grobmyer SR, Shiloh MU, Brause JE, Potter S, MacMicking JD, Dinauer MC, and Nathan CF (1999) Lethality of endotoxin in mice genetically deficient in the respiratory burst oxidase, inducible nitric oxide synthase, or both. Shock 11: 253-258.[Medline]
O'Connor M, Salzman AL, and Szabò C (1997) Role of peroxynitrite in the protein oxidation and apoptotic DNA fragmentation in vascular smooth muscle cells stimulated with bacterial lipopolysaccharide and interferon-gamma. Shock 8: 439-443.[Medline]
Obrosova IG, Mabley JG, Zsengeller Z, Charniauskaya T, Abatan OI, Groves JT, and Szabo C (2005) Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB J 19: 401-403.
Parratt JR (1997) Nitric oxide. A key mediator in sepsis and endotoxaemia. J Physiol Pharmacol 48: 493-506.[Medline]
Rixen D, Siegel JH, Espina N, and Bertolini M (1997) Plasma nitric oxide in posttrauma critical illness: a function of "sepsis" and the physiologic state severity classification quantifying the probability of death. Shock 7: 17-28.[Medline]
Salvemini D, Jensen MP, Riley DP, and Misko TB (1998a) Therapeutic manipulation of peroxynitrite. Drug News Perspect 4: 204-214.
Salvemini D, Riley DP, Lennon PJ, Wang ZQ, Currie MG, Macarthur H, and Misko TP (1999) Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage. Br J Pharmacol 127: 685-692.[CrossRef][Medline]
Salvemini D, Wang ZQ, Stern MK, Currie MG, and Misko TB (1998b) Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc Natl Acad Sci USA 95: 2659-2663.
Shimanovich R, Hannah S, Lynch V, Gerasimchuk N, Mody TD, Magda D, Sessler J, and Groves JT (2001) Mn(II)-texaphyrin as a catalyst for the decomposition of peroxynitrite. J Am Chem Soc 123: 3613-3614.[CrossRef][Medline]
Siegel JH, Greenspan M, and Del Guercio LRM (1967) Abnormal vascular tone, defective oxygen transport and myocardial failure in human septic shock. Ann Surg 165: 504-551.[Medline]
Stern MK, Jensen MP, and Kramer K (1996) Peroxynitrite decomposition catalysts. J Am Chem Soc 118: 8735-8736.[CrossRef]
Szabò C, Salzman AL, and Ischiropoulos H (1995) Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett 372: 229-232.[CrossRef][Medline]
Szabo C, Cuzzocrea S, Zingarelli B, O'Connor M, and Salzman AL (1997) Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly(ADP-ribose) synthetase by peroxynitrite. J Clin Investig 100: 723-735.[Medline]
Thiemermann C (1994) The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol 28: 45-79.[Medline]
Thiemermann C, Ruetten H, Wu CC, and Vane JR (1995) The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116: 2845-2851.[Medline]
Wray GM, Hinds CJ, and Thiemermann C (1998) Effects of inhibitors of poly(ADP-ribose) synthetase activity on hypotension and multiple organ dysfunction caused by endotoxin. Shock 10: 13-19.[Medline]
Yoshizumi M, Perrella MA, Burnett JC, and Lee ME (1993) Tumor necrosis factor down regulates an endothelial nitric oxide synthase mRNA by shortening it half life. Circ Res 73: 205-209.[Abstract]
Zingarelli B, Day BJ, Crapo JD, Salzman AL, and Szabo C (1997) The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 120: 259-267.[CrossRef][Medline]
Zingarelli B, Virag L, Szabò A, Cuzzocrea S, Salzman AL, and Szabo C (1998) Oxidation, tyrosine nitration and cytostasis induction in the absence of inducible nitric oxide synthase. Int J Mol Med 1: 787-795.[Medline]
This article has been cited by other articles:
|
|
 |
|
  B. Vollmar and M. D. Menger The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and Repair Physiol Rev, October 1, 2009; 89(4): 1269 - 1339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Liu, Y. Huang, R. I. Likhotvorik, L. Keshvara, and D. G. Hoyt Protein Never in Mitosis Gene A Interacting-1 (PIN1) regulates degradation of inducible nitric oxide synthase in endothelial cells Am J Physiol Cell Physiol, September 1, 2008; 295(3): C819 - C827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Meziani, H. Kremer, A. Tesse, C. Baron-Menguy, C. Mathien, H. A. Mostefai, N. Carusio, F. Schneider, P. Asfar, and R. Andriantsitohaina Human Serum Albumin Improves Arterial Dysfunction during Early Resuscitation in Mouse Endotoxic Model via Reduced Oxidative and Nitrosative Stresses Am. J. Pathol., December 1, 2007; 171(6): 1753 - 1761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wu and P. R. Mayeux Effects of the Inducible Nitric-Oxide Synthase Inhibitor L-N6-(1-Iminoethyl)-lysine on Microcirculation and Reactive Nitrogen Species Generation in the Kidney following Lipopolysaccharide Administration in Mice J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1061 - 1067. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|
 |
 |
 |
B (NF-